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Vein Signals
• Myocardial sleeves are known to extend into veins 
connected to the myocardium  (pulmonary veins, 
superior/inferior vena cava, coronary sinus, and 
Marshall’s vein). The pulmonary veins(PV) play a 
much more significant role in AF than the other 
veins.
• The sleeves are capable of generating ectopic 
electrical signals and initiating AF. 
• They display variability in conduction properties and 
refractoriness which may enable them to maintain 
AF through re-entry.
• Vein signals appear to be the primary contributors in 
paroxysmal AF.
• Re-entry in AF is believed to be primarily functional. 
However, this functional source is usually isolated to 
a common anatomic region (the pulmonary veins). 
Adapted from January et al., 2014, p. 12
• As an example, suppose patient Bob has rapid 
signals arising from 3 of the 4 pulmonary veins. As 
these signals enter the atrium, they depolarize it 
from several different directions at slightly different 
intervals. Some of these signals run around each 
other in a race for non-refractory tissue. Eventually, 
one of two things happens…
• The signals travel around the atria in 
discordant patterns along with additional 
signals still arising from the pulmonary 
veins, and AF perpetuates.
• All the signals dead end into refractory 
tissue, signals cease to arise from the 
PV’s, and AF is terminated. 
Rotors
• Complicated form of functional 
re-entry which appears to be 
more important in persistent AF 
(Spitzer et al., 2017, p. 31).
• Unlike anatomical re-entry with 
single wavefronts that encircle a 
non-excitable core, rotors have 
“singularities,” which are regions 
surrounded by spiral waves that 
disperse into the atrial “milieu” 
(Krummen et. al, 2015, p. 143). 
• Rotors display no or almost no
excitable gap, so there is 
essentially no opportunity for 
the circuit to yield to another 
signal unless it is overwhelming 
(Krummen et. al, 2015, p. 143).
• Rotors appear to be capable of
shifting within a 2-3cm2 area of 
myocardium. This capability has 
made it challenging to even 
prove their existence until 
recently. It also makes them 
difficult to locate, especially 
when there are multiple rotors 
(Krummen et. al, 2015, p. 143).
Importance
Atrial fibrillation(AF) is a common 
cardiac disturbance encountered in the 
healthcare field (January et al., 2014, p. 
6). Nurses ought to remain up to date 
with the current understanding and 
treatment of AF.
Definition
A rapid, irregularly, irregular atrial 
rhythm (Gutierrez et al., 2016, p.442). 
Diagnosis by ECG
• No p waves
• Irregularly, irregular R-R 
interval
• Possible presence of 
fibrillatory waves
Adapted from Gutierrez et al, 2016, p. 442.
Classifications
• Paroxysmal AF: Typically 
lasts <1 week and 
spontaneously converts 
to sinus rhythm.
• Persistent AF: Continuous 
AF that lasts >1 week.
• Long-standing: >1 year, 
but may still convert.
• Permanent: Sinus rhythm 
cannot be restored.
Adapted from Mitchell, 2017, p. 2-3
Symptoms
• May be asymptomatic
• Palpitations
• Presyncope
• Syncope
• Chest pain
• Shortness of breath
• Weakness
• Irregular pulse
Adapted from Gutierrez et al., 2016, p.446
Anatomical re-entry features a refractory core (typically 
scarred or ischemic tissue), a “slow” pathway, and a “fast” 
pathway. Signals travel around the core through the fast 
pathway and are slowed enough by the slow pathway to 
give the fast pathway time to become excitable again just 
before the slowed signal arrives. This forms a loop of re-
entry (Zaman et al., 2014, p. 49-50). See below.
Functional re-entry occurs with a region of myocardial tissue 
that is heterogenous in terms of its conductive properties. 
When an electrical signal passes through this area it may be 
slowed or even blocked in some areas while being conducted 
normally in other areas. The blocked signal often fragments in 
different directions, sometimes circling back on itself and 
forming a re-entrant loop (Zaman et al., 2014, p. 49-50). 
The distinction between anatomical and functional re-entry is
best understood as anatomical being fixed (scar tissue, valvular
tissue, etc.) and functional as being variable and often unstable 
(sometimes it will conduct normally, other times erratically). 
This often makes locating functional re-entrant circuits much 
more difficult than anatomical circuits. 
Management
Drug Therapy
Rhythm control: Amiodarone, Propafenone, Flecainide, 
Ibutilide, Dofetilide (January et al., 2014, p. 32)
Rate control: β1 antagonists, nondihydropyridine
calcium channel blockers, amiodarone, digoxin (January 
et al., 2014, p.29)
Anticoagulation: Beyond the scope of this presentation 
due to the complexity of the recommendations. See Norby 
et al., 2017, p. 238-249.
DC Cardioversion 
(Biphasic)
Normal or lower BMI: 100J was equally effective to 
200J in first shock success. Overweight or greater BMI:
200J was significantly more effective in first shock
success (Glover et al., 2008, p. 884).
“It is reasonable to perform transesophageal 
echocardiogram (TEE)” to rule out intracardiac 
thrombus formation (particularly in the left atrial 
appendage) prior to DCCV in stable AF patients with 
symptoms >48 hours or unknown symptom duration –
Class IIa recommendation (January et al., 2014, p. 33). 
Procedures
Ablation: Pulmonary Vein Isolation (PVI) – Venous 
catheters are advanced to the right atrium and punctured
through the atrial septum. An ablation catheter is then 
used to burn or freeze tissue around ostium of PV’s and a 
multi-electrode catheter is used to verify isolation 
(Hachem et al., 2018, p. 1).
Ablation: Focal Impulse and Rotor Modulation (FIRM) –
A basket catheter and real-time 3D mapping are utilized to 
identify singularities and ablation catheters are used to 
burn/freeze them. This is a relatively new and 
controversial therapy (Spitzer et al., 2017, p. 32-34).
MAZE: A maze of scar tissue is created in the atria 
around arrhythmogenic zones from which only one path 
leads to the rest of the myocardium. Techniques include 
radiofrequency (heat) ablation, cryoablation (cold), and 
surgical incisions. It is most commonly done during heart 
surgery for other problems such as CAD and valvular 
disease, but is also available by itself as a minimally 
invasive procedure (Sharples et al., 2018, p. 21). 
Left atrial appendage closure: The LAA is a common 
source of thromboembolism in patients with AF. There are 
multiple options available to close the LAA off from the left 
atrium such as ligation, Atriclip, WATCHMAN, and the 
Amplatzer Cardiac Plug (Cleveland Clinic, 2017). 
Excitable gap: The period of time between when a cardiac 
myocyte has repolarized (meaning it is now available to 
depolarize) and the time the next signal would normally 
arrive. In sinus rhythm, this would essentially be the time 
between the end of the T wave and the beginning of the 
next QRS complex in ventricular tissue (Surawicz & 
Knilans, 2008, p. 433). 
The excitable gap is a period where there is opportunity
for a different circuit to take over. This can mean that a 
rhythm such as atrial flutter is started via a PAC while some
arrhythmias are actually stopped because of other
premature beats that strike during an excitable gap,
making the tissue refractory to the arrhythmia’s impulse.
Terms to Know Pathophysiology Nursing Implications
• Be aware of the signs and symptoms of 
atrial fibrillation and expand assessment 
accordingly. For example, if a patient 
becomes short of breath, do not stop at a 
respiratory assessment. Examine the
patient’s rhythm if on telemetry or the
apical/radial pulse and consider ECG if 
orders are on standby. 
• Be able to identify atrial fibrillation on
ECG if telemetry is utilized in your work 
area.
• Ask the patient when symptoms first
started because this will be important in
establishing the need for TEE if DCCV is
considered.
• Obtain order to establish adequate IV
access if patient’s stability is in question.
• Anticipate orders for the typical
medications, dosages, IV push rates, and 
monitoring required for treatment of AF.
• Anticipate orders for anticoagulation – a 
“bridge” of a heparin/bivalirudin 
infusion is common until warfarin is
therapeutic. This may not be necessary 
depending on AF duration and the
agents utilized for anticoagulation.
• Be prepared to educate patients and 
caregivers about atrial fibrillation and be 
careful to distinguish it from ventricular 
fibrillation. Let them know that it is 
often controlled rather than fixed and 
that many people with AF lead normal 
lives.
Consequences
The rapid and chaotic electrical impulses in the atria
causes many small different areas to contract at different 
times. The result are atria that quiver, rather than squeeze, 
and fail to contribute their extra blood volume to 
ventricular diastolic filling. Thus, cardiac output may 
decrease and signs/symptoms of heart failure may 
present.
Some portions of the atria, particularly the left atrial 
appendage, may have blood stasis with resulting thrombus 
formation. Risk of a stroke from atrial fibrillation is
estimated to be increased 5-7 fold compared to the rest of 
the population (January et al., 2014, p. 8-9).
Sequela
• Thromboembolism (Schmid et al., 2011, p. 220)
• Heart failure (Gutierrez et al., 2016, p. 442)
• Treatment-associated problems such as bleeding risk 
with anticoagulation or exercise intolerance from 
beta blockers and/or nondihydropyridine calcium 
channel blockers.
References
Conclusions
The significance of atrial fibrillation on health 
cannot be overstated. AF as a primary diagnosis 
causes greater than 467,000 hospitalizations per 
year in the United States (January et al., 2014, p. 7). 
The causes of atrial fibrillation are multifactorial so 
maintaining control of it can be challenging for 
healthcare providers. This difficulty is evident in the 
fact that no single treatment is effective for 
everyone. 
As surgeons and electrophysiologists continue to 
search for and utilize new treatment options, such as 
WATCHMAN and FIRM, nurses in the field also need 
to stay current. A stronger understanding of the 
mechanisms underlying these options is important 
to providing excellent care and education to our 
patients. This author hopes to have enhanced the 
knowledge of other nurses to that end.
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Risk Factors
• Age > 65
• Hypertension
• Coronary artery disease
• Cardiomyopathy
• AV Valve disorders
• Hyperthyroidism
• Lung disease
Adapted from January et al, 2014, p.7
Rotor 2-D illustration. They are known to have
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epicardium, but are difficult to portray in 3-D view.
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